Zhuang, X., & Long, E. O. (2019). CD28 homolog is a strong activator of natural killer cells for lysis of B7H7(+) tumor cells. Cancer Immunol Res.
Chicago ZitierstilZhuang, Xiaoxuan, und Eric O. Long. "CD28 Homolog Is a Strong Activator of Natural Killer Cells for Lysis of B7H7(+) Tumor Cells." Cancer Immunol Res 2019.
MLA ZitierstilZhuang, Xiaoxuan, und Eric O. Long. "CD28 Homolog Is a Strong Activator of Natural Killer Cells for Lysis of B7H7(+) Tumor Cells." Cancer Immunol Res 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.